<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="28/11/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8947512" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8947512</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Other" id="T1" lex="sterol_dependent_LDL-receptor_gene_transcription"><term sem="Lipid" id="A1">Sterol</term> dependent <term sem="DNA_domain_or_region" id="T2" lex="LDL-receptor_gene">LDL-receptor gene</term> transcription</term> in <term sem="Cell_natural" id="T3" lex="lymphocyte">lymphocytes</term> from normal and <term sem="Multicellular_organism_natural" id="T4" lex="CML_patient">CML <term sem="Multicellular_organism_natural" id="T5" lex="patient">patients</term></term>.</sentence>
<event id="E1">
<type class="Transcription" />
<theme idref="T2" />
<clue>Sterol dependent LDL-receptor gene <clueType>transcription</clueType> in lymphocytes from normal and CML patients.</clue>
</event>
<event id="E300">
<type class="Positive_regulation" />
<theme idref="E1" />
<cause idref="A1" />
<clue>Sterol <clueType>dependent</clueType> LDL-receptor gene transcription <clueLoc>in lymphocytes from normal</clueLoc> and CML <clueLoc>patients</clueLoc>.</clue>
</event>
<event id="E301">
<type class="Positive_regulation" />
<theme idref="E1" />
<cause idref="A1" />
<clue>Sterol <clueType>dependent</clueType> LDL-receptor gene transcription <clueLoc>in lymphocytes from</clueLoc> normal and <clueLoc>CML patients</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="DNA_domain_or_region" id="T6" lex="sterol_regulatory_element">Sterol regulatory element</term> (<term sem="DNA_domain_or_region" id="T7" lex="SRE">SRE</term>) has been recognized to regulate various key <term sem="DNA_family_or_group" id="T8" lex="gene">genes</term> coding for especially <term sem="Protein_family_or_group" id="T9" lex="low_density_lipoprotein_(LDL)-receptor"><term sem="Protein_molecule" id="T10" lex="low_density_lipoprotein">low density lipoprotein</term> (<term sem="Protein_molecule" id="T11" lex="LDL">LDL</term>)-receptor</term>, <term sem="Protein_family_or_group" id="T12" lex="3-hydroxy-3-methylglutaryl_coenzyme_A_(HMG-CoA)_reductase">3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase</term> and <term sem="Protein_family_or_group" id="T13" lex="HMG-CoA_synthase">HMG-CoA synthase</term> known to play a crucial role in the <term sem="Other" id="T14" lex="cholesterol_feedback_mechanism"><term sem="Lipid" id="T15" lex="cholesterol">cholesterol</term> feedback mechanism</term>.</sentence>
<event id="E3">
<type class="Regulation" />
<theme idref="T9" />
<cause idref="T7" />
<clue>Sterol regulatory element (SRE) has been recognized to <clueType>regulate</clueType> various key genes coding for especially low density lipoprotein (LDL)-receptor, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and HMG-CoA synthase known to play a crucial role in the cholesterol feedback mechanism.</clue>
</event>
<event id="E4">
<type class="Regulation" />
<theme idref="T12" />
<cause idref="T7" />
<clue>Sterol regulatory element (SRE) has been recognized to <clueType>regulate</clueType> various key genes coding for especially low density lipoprotein (LDL)-receptor, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and HMG-CoA synthase known to play a crucial role in the cholesterol feedback mechanism.</clue>
</event>
<event id="E5">
<type class="Regulation" />
<theme idref="T13" />
<cause idref="T7" />
<clue>Sterol regulatory element (SRE) has been recognized to <clueType>regulate</clueType> various key genes coding for especially low density lipoprotein (LDL)-receptor, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and HMG-CoA synthase known to play a crucial role in the cholesterol feedback mechanism.</clue>
</event>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="T14" />
<cause idref="T9" />
<clue>Sterol regulatory element (SRE) has been recognized to regulate various key genes coding for especially low density lipoprotein (LDL)-receptor, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and HMG-CoA synthase known to <clueType>play</clueType> a <clueType>crucial role</clueType> <linkTheme>in</linkTheme> the cholesterol feedback mechanism.</clue>
</event>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="T14" />
<cause idref="T12" />
<clue>Sterol regulatory element (SRE) has been recognized to regulate various key genes coding for especially low density lipoprotein (LDL)-receptor, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and HMG-CoA synthase known to <clueType>play</clueType> a <clueType>crucial role</clueType> <linkTheme>in</linkTheme> the cholesterol feedback mechanism.</clue>
</event>
<event id="E8">
<type class="Positive_regulation" />
<theme idref="T14" />
<cause idref="T13" />
<clue>Sterol regulatory element (SRE) has been recognized to regulate various key genes coding for especially low density lipoprotein (LDL)-receptor, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and HMG-CoA synthase known to <clueType>play</clueType> a <clueType>crucial role</clueType> <linkTheme>in</linkTheme> the cholesterol feedback mechanism.</clue>
</event>
<sentence id="S3">The deranged <term sem="Other" id="T16" lex="cholesterol_feedback_mechanism"><term sem="Lipid" id="T17" lex="cholesterol">cholesterol</term> feedback mechanism</term> has been widely recognised in initiation as well as progression of various types of <term sem="Other" id="T18" lex="cancer">cancers</term> including <term sem="Other" id="T19" lex="chronic_myeloid_leukaemia">chronic myeloid leukaemia</term> (<term sem="Other" id="T20" lex="CML">CML</term>).</sentence>
<event id="E9">
<type class="Regulation" />
<theme idref="T16" />
<clue>The <clueType>deranged</clueType> cholesterol feedback mechanism has been widely recognised in initiation as well as progression of various types of cancers including chronic myeloid leukaemia (CML).</clue>
</event>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="T18" />
<clue>The deranged cholesterol feedback mechanism has been widely recognised in <clueType>initiation</clueType> as well as progression <linkTheme>of</linkTheme> various types of cancers including chronic myeloid leukaemia (CML).</clue>
</event>
<event id="E11">
<type class="Positive_regulation" />
<theme idref="T20" />
<clue>The deranged cholesterol feedback mechanism has been widely recognised in <clueType>initiation</clueType> as well as progression <linkTheme>of</linkTheme> various types of <corefTheme>cancers</corefTheme> including chronic myeloid leukaemia (CML).</clue>
</event>
<event id="E12">
<type class="Positive_regulation" />
<theme idref="T18" />
<clue>The deranged cholesterol feedback mechanism has been widely recognised in initiation as well as <clueType>progression</clueType> <linkTheme>of</linkTheme> various types of cancers including chronic myeloid leukaemia (CML).</clue>
</event>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="T20" />
<clue>The deranged cholesterol feedback mechanism has been widely recognised in initiation as well as <clueType>progression</clueType> <linkTheme>of</linkTheme> various types of <corefTheme>cancers</corefTheme> including chronic myeloid leukaemia (CML).</clue>
</event>
<event id="E14">
<type class="Correlation" />
<theme idref="E9" />
<theme idref="E10" />
<clue>The deranged cholesterol feedback mechanism has been widely <clueType>recognised</clueType> <linkTheme>in</linkTheme> initiation as well as progression of various types of cancers including chronic myeloid leukaemia (CML).</clue>
</event>
<event id="E15">
<type class="Correlation" />
<theme idref="E9" />
<theme idref="E11" />
<clue>The deranged cholesterol feedback mechanism has been widely <clueType>recognised</clueType> <linkTheme>in</linkTheme> initiation as well as progression of various types of cancers including chronic myeloid leukaemia (CML).</clue>
</event>
<event id="E16">
<type class="Correlation" />
<theme idref="E9" />
<theme idref="E12" />
<clue>The deranged cholesterol feedback mechanism has been widely <clueType>recognised</clueType> <linkTheme>in</linkTheme> initiation as well as progression of various types of cancers including chronic myeloid leukaemia (CML).</clue>
</event>
<event id="E17">
<type class="Correlation" />
<theme idref="E9" />
<theme idref="E13" />
<clue>The deranged cholesterol feedback mechanism has been widely <clueType>recognised</clueType> <linkTheme>in</linkTheme> initiation as well as progression of various types of cancers including chronic myeloid leukaemia (CML).</clue>
</event>
<sentence id="S4">Consequently, the present study was addressed to understand this phenomenon and revealed the existence of a <term sem="Protein_molecule" id="T21" lex="unique_47_kDa_protein_factor">unique 47 kDa protein factor</term> having affinity for this <term sem="DNA_domain_or_region" id="T22" lex="SRE_sequence">SRE sequence</term> in <term sem="Cell_natural" id="T23" lex="lymphocyte">lymphocytes</term> from <term sem="Multicellular_organism_natural" id="T24" lex="normal_subject">normal subjects</term> as well as its absence in <term sem="Cell_natural" id="T25" lex="lymphocyte">lymphocytes</term> from untreated <term sem="Other" id="T26" lex="CML">CML</term> <term sem="Multicellular_organism_natural" id="T27" lex="patient">patients</term>.</sentence>
<event id="E18">
<type class="Binding" />
<theme idref="T21" />
<theme idref="T22" />
<clue>Consequently, the present study was addressed to understand this phenomenon and revealed the existence of a unique 47 kDa protein factor <clueType>having affinity</clueType> <linkTheme>for</linkTheme> this SRE sequence in lymphocytes from normal subjects as well as its absence in lymphocytes from untreated CML patients.</clue>
</event>
<event id="E19">
<type class="Gene_expression" />
<theme idref="T21" />
<clue>Consequently, the present study was addressed to understand this phenomenon and revealed the <clueType>existence</clueType> <linkTheme>of</linkTheme> a unique 47 kDa protein factor having affinity for this SRE sequence <clueLoc>in lymphocytes from normal subjects</clueLoc> as well as its absence in lymphocytes from untreated CML patients.</clue>
</event>
<event assertion="non-exist" id="E20">
<type class="Gene_expression" />
<theme idref="T21" />
<clue>Consequently, the present study was addressed to understand this phenomenon and revealed the existence of a unique 47 kDa protein factor having affinity for this SRE sequence in lymphocytes from normal subjects as well as <corefTheme>its</corefTheme> <clueType>absence</clueType> <clueLoc>in lymphocytes from untreated CML patients.</clueLoc></clue>
</event>
<sentence id="S5">However, this factor appeared when the <term sem="Other" id="T28" lex="CML">CML</term> <term sem="Multicellular_organism_natural" id="T29" lex="patient">patients</term> achieved <term sem="Other" id="T30" lex="complete_haematological_remission">complete haematological remission</term> (<term sem="Other" id="T31" lex="CHR">CHR</term>) through <term sem="Other" id="T32" lex="alpha-interferon_therapy"><term sem="Protein_molecule" id="T33" lex="alpha-interferon">alpha-interferon</term> therapy</term>.</sentence>
<event id="E21">
<type class="Negative_regulation" />
<theme idref="T28" />
<cause idref="T33" />
<clue>However, this factor appeared when the CML patients <clueType>achieved</clueType> complete haematological <clueType>remission</clueType> (CHR) through alpha-interferon therapy.</clue>
</event>
<event id="E50">
<type class="Gene_expression" />
<theme idref="T21" />
<clue>However, <corefTheme>this factor</corefTheme> <clueType>appeared</clueType> when the CML patients achieved complete haematological remission (CHR) through alpha-interferon therapy.</clue>
</event>
<event id="E51">
<type class="Positive_regulation" />
<theme idref="E50" />
<cause idref="E21" />
<clue>However, this factor appeared <linkCause>when</linkCause> the CML patients achieved complete haematological remission (CHR) through alpha-interferon therapy.</clue>
<comment>NO CLUETYPE</comment>
</event>
<sentence id="S6">Further, an inverse relationship was also observed between <term sem="Other" id="T34" lex="sterol_modulated_LDL-receptor_gene_transcription"><term sem="Lipid" id="A6">sterol</term> modulated <term sem="DNA_domain_or_region" id="T35" lex="LDL-receptor_gene"><term sem="Protein_molecule" id="T36" lex="LDL">LDL</term>-receptor gene</term> transcription</term> and the binding affinity of this <term sem="Protein_molecule" id="T37" lex="47_kDa_factor">47 kDa factor</term> to the <term sem="DNA_domain_or_region" id="T38" lex="SRE_sequence">SRE sequence</term>.</sentence>
<event id="E22">
<type class="Transcription" />
<theme idref="T35" />
<clue>Further, an inverse relationship was also observed between sterol modulated LDL-receptor gene <clueType>transcription</clueType> and the binding affinity of this 47 kDa factor to the SRE sequence.</clue>
</event>
<event id="E23">
<type class="Regulation" />
<theme idref="E22" />
<cause idref="A6" />
<clue>Further, an inverse relationship was also observed between sterol <clueType>modulated</clueType> LDL-receptor gene transcription and the binding affinity of this 47 kDa factor to the SRE sequence.</clue>
</event>
<event id="E24">
<type class="Binding" />
<theme idref="T37" />
<theme idref="T38" />
<clue>Further, an inverse relationship was also observed between sterol modulated LDL-receptor gene transcription and the <clueType>binding</clueType> affinity <linkTheme>of</linkTheme> this 47 kDa factor <linkTheme>to</linkTheme> the SRE sequence.</clue>
</event>
<event id="E25">
<type class="Correlation" />
<theme idref="E23" />
<theme idref="E24" />
<clue>Further, an <clueType>inverse relationship</clueType> was also observed <linkTheme>between</linkTheme> sterol modulated LDL-receptor gene transcription and the binding affinity of this 47 kDa factor to the SRE sequence.</clue>
</event>
<sentence id="S7">Based upon these results we propose that <term sem="Protein_molecule" id="T39" lex="alpha-interferon">alpha-interferon</term> through its <term sem="Protein_molecule" id="A7">receptor</term> initiates <term sem="Other" id="T40" lex="phosphatidic_acid_dependent_signalling"><term sem="Organic_compound_other" id="T41" lex="phosphatidic_acid">phosphatidic acid</term> dependent signalling</term> which in turn regulates the affinity of <term sem="Protein_molecule" id="T42" lex="47_kDa_sterol_regulatory_element_binding_factor">47 kDa sterol regulatory element binding factor</term> as well as <term sem="Other" id="T43" lex="LDL-receptor_gene_transcription"><term sem="DNA_domain_or_region" id="T44" lex="LDL-receptor_gene"><term sem="Protein_molecule" id="T45" lex="LDL">LDL</term>-receptor gene</term> transcription</term> in <term sem="Cell_natural" id="T46" lex="lymphocyte">lymphocytes</term> from <term sem="Multicellular_organism_natural" id="T47" lex="CML_patient"><term sem="Other" id="T48" lex="CML">CML</term> <term sem="Multicellular_organism_natural" id="T49" lex="patient">patients</term></term>.</sentence>
<event id="E26">
<type class="Cell_communication" />
<theme idref="T41" />
<clue>Based upon these results we propose that alpha-interferon through its receptor initiates phosphatidic acid <linkTheme>dependent</linkTheme> <clueType>signalling</clueType> which in turn regulates the affinity of 47 kDa sterol regulatory element binding factor as well as LDL-receptor gene transcription in lymphocytes from CML patients.</clue>
</event>
<event id="E27">
<type class="Positive_regulation" />
<theme idref="E26" />
<cause idref="T39" />
<clue>Based upon these results we propose that alpha-interferon through its receptor <clueType>initiates</clueType> phosphatidic acid dependent signalling which in turn regulates the affinity of 47 kDa sterol regulatory element binding factor as well as LDL-receptor gene transcription in lymphocytes from CML patients.</clue>
</event>
<event id="E28">
<type class="Positive_regulation" />
<theme idref="E27" />
<cause idref1="A7" idref="T39" />
<clue>Based upon these results we propose that alpha-interferon <linkCause>through</linkCause> its receptor initiates phosphatidic acid dependent signalling which in turn regulates the affinity of 47 kDa sterol regulatory element binding factor as well as LDL-receptor gene transcription in lymphocytes from CML patients.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E29">
<type class="Binding" />
<theme idref="T42" />
<theme idref="T38" />
<clue>Based upon these results we propose that alpha-interferon through its receptor initiates phosphatidic acid dependent signalling which in turn regulates the <clueType>affinity</clueType> <linkTheme>of</linkTheme> 47 kDa sterol regulatory element binding factor as well as LDL-receptor gene transcription in lymphocytes from CML patients.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event id="E30">
<type class="Regulation" />
<theme idref="E29" />
<cause idref="T39" />
<clue>Based upon these results we propose that alpha-interferon through its receptor initiates phosphatidic acid dependent signalling which in turn <clueType>regulates</clueType> the affinity of 47 kDa sterol regulatory element binding factor as well as LDL-receptor gene transcription <clueLoc>in lymphocytes from CML patients.</clueLoc></clue>
</event>
<event id="E31">
<type class="Transcription" />
<theme idref="T44" />
<clue>Based upon these results we propose that alpha-interferon through its receptor initiates phosphatidic acid dependent signalling which in turn regulates the affinity of 47 kDa sterol regulatory element binding factor as well as LDL-receptor gene <clueType>transcription</clueType> in lymphocytes from CML patients.</clue>
</event>
<event id="E32">
<type class="Regulation" />
<theme idref="E30" />
<cause idref="T39" />
<clue>Based upon these results we propose that alpha-interferon through its receptor initiates phosphatidic acid dependent signalling which in turn <clueType>regulates</clueType> the affinity of 47 kDa sterol regulatory element binding factor as well as LDL-receptor gene transcription <clueLoc>in lymphocytes from CML patients.</clueLoc></clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
